Literature DB >> 781393

[The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

J Knolle, M Born, G Hess, O Klinge, W Arnold, H Bitz, K H Meyer.   

Abstract

129 blood donors found to be HBsAg-positive on routine testing were studied for evidence of hepatic disease. Twelve had already lost the antigen from the serum when histologically examined. None of these has had clinical or histological evidence of inflammatory liver disease. Two of the 129 patients showed mild icteric hepatitis, cleared the antigen during the follow up and became anti-HBs positive. The remaining 115 patients who appeared clinically healthy and who had no history of previous icteric liver disease remained HBsAg positive during a mean follow up period of 17.3 +/- 3.0 months. Forty patients from these had a normal liver histology and 37 mild to distinct steatosis but no signs of inflammatory liver disease. 11 patients a mild nonspecific mesenchymal activity but no focal necrosis, 16 patients had mild infiltration in portal tracts and a few necrotic parenchymal cells with mesenchymal reaction, 6 patients had chronic persistent hepatitis, 4 chronic aggressive hepatitis, and 1 definite posthepatic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781393     DOI: 10.1007/bf01619572

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  61 in total

1.  Asymptomatic hapatic disease in blood donors with hepatitis B antigenemia.

Authors:  S B Vittal; D Dourdourekas; N Shobassy; M Gerber; M Telischi; P B Szanto; F Steigmann; B F Clowdus
Journal:  Am J Clin Pathol       Date:  1974-11       Impact factor: 2.493

2.  Asymptomatic hepatitis B antigen carriers: a clinicopathological study.

Authors:  M Fainaru; I S Levij
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1974-06

3.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

4.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

5.  Evidence against recessive inheritance of susceptibility to the chronic carrier state for hepatitis B antigen.

Authors:  G N Vyas
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

6.  Liver function and histology in asymptomatic Chinese military personnel with hepatitis B antigenemia.

Authors:  K E Anderson; S C Sun; H S Berg; N K Chang
Journal:  Am J Dig Dis       Date:  1974-08

7.  Hepatitis B antigenemia in apparently healthy blood donors.

Authors:  F M Griffin
Journal:  JAMA       Date:  1973-11-12       Impact factor: 56.272

8.  Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers.

Authors:  J O Nielsen; M H Nielsen; P Elling
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

9.  [Demonstration of inapparent infections within an outbreak of communicable jaundice with positive Australia(SH)-antigen finding].

Authors:  A Schober; R Thomssen; U Kaboth; R Worch
Journal:  Dtsch Med Wochenschr       Date:  1970-12-18       Impact factor: 0.628

10.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

View more
  4 in total

1.  IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.

Authors:  H H Dromeyer; W Arnold; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

2.  High risk groups for hepatitis B virus infection in a university hospital staff as determined by detection of HB antigens, antibodies, and Dane particles.

Authors:  N Scheiermann; E K Kuwert; E Pieringer; R Dermietzel
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

3.  [Spread of hepatitis B virus infection among family contacts of asymptomatic HBsAg carriers (author's transl)].

Authors:  H H Dormeyer; G Hess; M Born; H Schönborn; W Arnold; J Knolle; B Zöller
Journal:  Klin Wochenschr       Date:  1979-12-03

4.  Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.

Authors:  W Arnold; G Hess; R H Purcell; P M Kaplan; J L Gerin; K H Meyer
Journal:  Klin Wochenschr       Date:  1978-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.